SCHEMBL19239125

SCHEMBL19239125

c1ccc(N(c2ccccc2)c2cccc(-c3ccc4c(c3)-c3ccc(N(c5ccccc5)c5ccc6c(c5)-c5ccccc5C6)cc3C4)c2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 5/20 0.43
CYP3A4 P08684 4/20 0.43
CYP2C19 P33261 3/20 0.43
CYP2D6 P10635 2/20 0.43
CYP2C9 P11712 2/20 0.43
HSD17B10 Q99714 2/20 0.43
ALDH1A1 P00352 3/20 0.41
MAPT P10636 3/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
NPC1 O15118 3/20 0.41
RAB9A P51151 3/20 0.41
HPGD P15428 2/20 0.41
LMNA P02545 2/20 0.41
KDM4E B2RXH2 1/20 0.41
SRD5A2 P31213 1/20 0.40
CNR1 P21554 1/20 0.39
HIF1A Q16665 1/20 0.38
MMP12 P39900 1/20 0.37
MMP13 P45452 1/20 0.37
TDP2 O95551 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21730739 0.92 CNR1 (0.43) CYP1A2CYP3A4CYP2C19CYP2D6CYP2C9
SCHEMBL25000680 0.91 ALDH1A1 (0.38) CYP1A2CYP3A4CYP2C19CYP2D6CYP2C9
SCHEMBL19239124 0.89 MMP12 (0.40) CYP1A2CYP3A4CYP2C19CYP2D6CYP2C9
SCHEMBL26240139 0.88 MAPT (0.43) CYP1A2CYP3A4CYP2C19CYP2D6CYP2C9
SCHEMBL5446075 0.88 CYP1A2 (0.49) CYP1A2CYP3A4CYP2C19CYP2D6CYP2C9
SCHEMBL25806782 0.88 CYP1A2 (0.49) CYP1A2CYP3A4CYP2C19CYP2D6CYP2C9
SCHEMBL14018411 0.88 TDP2 (0.41) CYP1A2CYP3A4CYP2C19CYP2D6CYP2C9
SCHEMBL24923295 0.88 CYP1A2 (0.49) CYP1A2CYP3A4CYP2C19CYP2D6CYP2C9
SCHEMBL804482 0.88 CYP1A2 (0.49) CYP1A2CYP3A4CYP2C19CYP2D6CYP2C9
SCHEMBL13720534 0.87 CYP1A2 (0.53) CYP1A2CYP3A4CYP2C19CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170237013-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2017-08-17 US disclosed
US-20170237013-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2017-08-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170237013-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF EML4, EBPL, NFE2L2 CYP1A2 2594/4885CYP3A4 1729/4885CYP2C19 1681/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.